Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis

Table 1 Characteristics of the Patient Cohort With Cardiac Sarcoidosis^a

Characteristic	Value (N = 83)
Systolic blood pressure, mm Hg	113.6 ± 18.8
Diastolic blood pressure, mm Hg	70.9 ± 10.7
Heart rate, bpm	72.7 ± 15.6
BMI, kg/m²	29.4 ± 6.1
Hypertension	31 (37.3)
Diabetes mellitus	16 (19.3)
Dyslipidemia	25 (30.1)
Coronary artery disease^b	5 (6.0)
Coronary catheterization	54 (65.1)
Prior immunosuppressive treatment	57 (68.7)
Systemic corticosteroids	57 (68.7)
MMF	10 (12.0)
Positive endomyocardial biopsy	25 (30.1)
VT/VF before CS diagnosis	32 (38.5)
ICD before CS diagnosis	32 (38.5)
Pacemaker before CS diagnosis	38 (45.8)

Abbreviations: bpm beats per minute; BMI body mass index; CS cardiac sarcoidosis; ICD implantable cardioverter defibrillator; MMF mycophenolate mofetil; VT/VF ventricular tachycardia/ventricular fibrillation
^a Values are mean ± SD or No. (%)
^b Four patients with a previous diagnosis of stable coronary artery disease had subsequent histologic diagnoses of CS, and 1 had findings on cardiac magnetic resonance of patchy, active inflammation of the left ventricle in an area of the ventricle unaffected by previous ischemia; all had a final coronary angiogram that showed no substantial coronary stenosis

ISSN: 1471-2261